Product NDC: | 10515-145 |
Proprietary Name: | Ampicillin |
Non Proprietary Name: | Ampicillin Sodium |
Active Ingredient(s): | 250 mg/1 & nbsp; Ampicillin Sodium |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10515-145 |
Labeler Name: | GC Hanford Manufacturing Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA063145 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100917 |
Package NDC: | 10515-145-00 |
Package Description: | 10 VIAL, GLASS in 1 TRAY (10515-145-00) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS |
NDC Code | 10515-145-00 |
Proprietary Name | Ampicillin |
Package Description | 10 VIAL, GLASS in 1 TRAY (10515-145-00) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS |
Product NDC | 10515-145 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ampicillin Sodium |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20100917 |
Marketing Category Name | ANDA |
Labeler Name | GC Hanford Manufacturing Company |
Substance Name | AMPICILLIN SODIUM |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient] |